CD274 and neoplasm: We would then speculate that immune therapies targeting the PD-L1/PD-1 pathway might be especially effective in tumors where this immune suppressive axis is operational, and that reversing the balance towards an immune protective environment would rekindle and strengthen a pre-existing anti-tumor immune response.